$CFBK

Beerman Kevin J buys CF Bankshares Inc (CFBK) shares for $5,172

Kevin J. Beerman, EVP & Chief Financial Officer of CF Bankshares Inc. (CFBK), purchased 217 shares of the company's common stock for $5,172. This transaction increased his direct ownership to 25,317 shares. The company recently declared quarterly cash dividends and updated its outstanding share count following a non-voting stock conversion.

Original reporting
Investing.com India · Investing.com
Published Dec 13, 2025, 1:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Dec 13, 2025, 1:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CFBK
Bullish
medium confidence
Mentioned
$CFBK
Relevance
6/10
AlphAI data visualization · based on Investing.com India
Decision brief

The 30-second read

$CFBKBullishMed
01

Why it matters

The insider's purchase indicates internal confidence, which could positively influence investor sentiment. However, the impact is limited given the size of the transaction relative to total holdings.

02

Market read

The transaction has moderate relevance for investors focusing on insider activity and regional banking stocks.

03

What to watch

Recent earnings reports, macroeconomic conditions, and broader industry trends should be considered before making trading decisions.

Relevance 6/10Timing: Immediate, as the transaction occurred recently.

Background

Kevin J. Beerman, CFO of CF Bankshares, increased his stake by purchasing 217 shares for $5,172, raising his ownership to 25,317 shares. The company recently declared dividends and updated its share count following a stock conversion.

Company-level read

Ticker impact

$CFBKBullishMedium confidence
Context

The insider transaction by CF Bankshares' CFO indicates potential confidence in the company's prospects.

Expected impact

Potential slight upward movement in the short term, contingent on broader market conditions.

Evidence & confidence

Insider buying can signal confidence, but a single transaction's impact is limited without additional context.

Market effects

The banking sector may experience minor positive sentiment due to insider confidence in regional banks.

Limited regional impact, primarily affecting investors in CF Bankshares.

Negligible, as this is a regional bank and a single insider transaction.

Counterpoint

The insider purchase might be motivated by personal reasons unrelated to company prospects, so it should not be overinterpreted.

Key entities

  • CF Bankshares Inc.

    A regional bank with operations focused on community banking services.

  • Kevin J. Beerman

    EVP & Chief Financial Officer of CF Bankshares Inc.

Related articles

$CFBKMed

CF BANKSHARES INC., PARENT OF CFBANK NA, REPORTS RESULTS FOR THE 2nd QUARTER 2026

CF BANKSHARES INC. (CFBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cfbk-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Parent of CFBank, NA PRESS RELEASE FOR IMMEDIATE RELEASE: July 28, 2026 For Further Information: Timothy T. O'Dell, President & CEO Phone: 614.318.4660 Email: timodell@cfbankmail.com CF BANKSHARES INC., PARENT OF CFBANK NA, R

$GLUEMedAI 8/10

Monte Rosa's MRT-8102 Drives 80%-90% NEK7 Degradation In Phase 1

Monte Rosa Therapeutics (GLUE) reported Phase 1 results showing MRT-8102 achieved 80%-90% NEK7 degradation, reducing biomarkers linked to cardiovascular disease. The treatment was well-tolerated with no serious adverse events. GLUE plans Phase 2 trials in 2026-2027 for coronary artery disease, gout, and hidradenitis suppurativa. GLUE stock is currently down 5.74% at $11.24.

$HDBMed

Top 10@10 | D-Street’s losing streak hits 8 weeks, HDFC Bank and Kotak get new CEOs, Tata Trusts flag concerns

HDFC Bank appointed Anup Bagchi as MD & CEO for a 3-year term, approved by RBI. Kotak Mahindra Bank received RBI approval for Anup Kumar Saha as next MD & CEO, effective January 1, 2027. Tata Trusts raised concerns over a proposed restructuring at Tata Sons. IRDAI aims to improve insurance sector efficiency, while Mahindra reported a 15% increase in September auto sales.